Skip to Content
Authors McAchran SE, Daneshgari F
Author Profile(s)
Journal Clin Obstet Gynecol Volume: 50 Issue: 3 Pages: 735-44
Publish Date 2007 Sep
PubMed ID 17762421

In the last 10 years, sacral neuromodulation has evolved from an experimental therapy to a safe and proven treatment option for patients with a variety of complex lower urinary tract disorders. It is currently Food and Drug Administration approved for the following indications: intractable urge incontinence, urgency-frequency, and nonobstructive urinary retention. Herein, we will discuss some of the factors complicating incontinence treatment in the elderly population paying particular attention to sacral neuromodulation, its history, indications, and applications within the elderly female population. Copyright © 2018 The Board of Regents of the University of Wisconsin System